Loading patent…
AssigneeLivtech, Inc.
InventorsKoji NAKAMURA, Kentaro OKAMURA, Maki TAMURA, Hiroyuki YANAI, Toru KANKE, Naoya TSURUSHITA, Shankar KUMAR
Estimating the term…
The present invention provides: an antibody which specifically reacts with hTROP-2 and has anti-tumor activity in vivo (particularly, a humanized antibody); a hybridoma which produces the aforementioned antibody; a conjugate of the aforementioned antibody and a drug; a pharmaceutical composition for diagnosing or treating a tumor; a method for detecting a tumor; and a kit for detecting or diagnosing a tumor.
An antibody against human TROP-2 in which an H chain V region of the antibody consists of the amino acid sequence shown in SEQ ID NO:
An antibody against human TROP-2 in which an H chain V region of the antibody consists of the amino acid sequence shown in SEQ ID NO:
13-15. (canceled)
19-20. (canceled)
23-25. (canceled)
30-31. (canceled)
33-34. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.